US Stock MarketDetailed Quotes
PFE Pfizer
- 25.650
- +0.520+2.07%
Close Nov 22 16:00 ET
- 25.600
- -0.050-0.19%
Post 19:59 ET
145.36BMarket Cap34.20P/E (TTM)
25.750High25.099Low41.90MVolume25.180Open25.130Pre Close1.07BTurnover0.74%Turnover Ratio69.32P/E (Static)5.67BShares31.05752wk High1.58P/B145.15BFloat Cap24.10552wk Low1.67Dividend TTM5.66BShs Float53.878Historical High6.51%Div YieldTTM2.59%Amplitude5.393Historical Low25.583Avg Price1Lot Size
About Pfizer Company
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Company Profile
SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees88000
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323
Websitehttp://www.pfizer.com
Company Executives
- Name
- Position
- Salary
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 21.56M
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- Aamir Malik
- Chief Commercial Officer, U.S. and Executive Vice President
- 5.42M
- Lidia L. Fonseca
- Chief Digital and Technology Officer and Executive Vice President
- --
- Rady A. Johnson
- Chief Compliance, Quality and Risk Officer and Executive Vice President
- --
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Dr. Mikael Dolsten, M.D.,PhD
- Chief Scientific Officer and President, Pfizer Research and Development
- 8.86M
- Michael McDermott
- Executive Vice President and Chief Global Supply Officer
- --
- Dr. Chris Boshoff, M.D.,PhD
- Executive Vice President and Chief Oncology Officer
- --
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 5.28M
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Douglas M. Lankler
- Executive Vice President and General Counsel
- 5.48M
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Mortimer J. Buckley
- Director
- --
- Cyrus Taraporevala
- Director
- --
- Suzanne Nora Johnson
- Independent Director
- 410.00K
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 360.00K
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 391.40K
- Joseph J. Echevarria
- Independent Director
- 390.00K
- James Robert Quincey
- Independent Director
- 380.00K
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 363.00K
- Dr. Helen H. Hobbs, M.D.
- Independent Director
- 410.00K
- Shantanu Narayen
- Lead Independent Director
- 430.00K
- Ronald E. Blaylock
- Independent Director
- 380.00K
- James C. Smith
- Independent Director
- 390.00K
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 417.20K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
